ORLANDO,
Fla., Sept. 19, 2024 /PRNewswire/ -- LightPath
Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," or
"we"), a leading global, vertically integrated provider of thermal
imaging cores, custom optical assemblies, photonics and infrared
solutions for the industrial, commercial, defense,
telecommunications, and medical industries, today announced
financial results for its fiscal 2024 fourth quarter and full year
ended June 30, 2024.
Fiscal 2024 Full Year & Fourth Quarter
Highlights:
- Revenue of $8.6 million for the
fourth quarter of fiscal 2024; revenue of $31.7 million for the full fiscal year 2024
- 28% and 20% of revenue, respectively, for customized lens
assemblies and solutions and related engineering services, or
LightPath 2.0 as we refer to these product groups
- Total backlog at June 30, 2024,
of $19.3 million
- Net loss for the fourth quarter of fiscal 2024 was $2.4 million; net loss of $8.0 million for the full fiscal year 2024
- EBITDA* loss for the fourth quarter of fiscal 2024 was
$1.3 million; EBITDA* loss of
$3.7 million for the full fiscal year
2024
- Achieved Key Qualification Milestone with Lockheed Martin for
US Army Missile Program
- Successfully Transitioned Key Customer from Germanium to
BlackDiamond Glass Optics
- Released First AI-Ready EdgeIR Cameras
Management Commentary
LightPath's President and Chief Executive Officer Sam Rubin stated, "Looking back at fiscal 2024,
LightPath took significant steps in our strategic plan to position
the Company for growth. We continued transitioning from a component
provider to a custom thermal imaging solutions provider while
pursuing our three pillars of growth: automotive, defense,
and camera solutions."
"Throughout the year, we demonstrated the potential of our
thermal imaging cameras through each introduction of
application-specific variations. We introduced new versions of the
Mantis camera, including a high-temperature furnace monitoring
camera and a long-range detection camera, as well as AI-enabled
thermal cameras. Each one of these cameras introduces capabilities
previously unavailable within a single camera. The development of
these specially tuned cameras was enabled by our acquisition of
Visimid in July 2023."
"Our strategic decision to focus on defense began to pay
dividends as we announced our work with Lockheed Martin on a
next-generation missile project. The work on this project will
influence LightPath over the long term, and should Lockheed secure
the project, it would be a transformative opportunity for the
Company. Since being chosen for this project, we have continually
hit our milestones and have now qualified to ship air worthy
units."
Mr. Rubin concluded, "As a result of China's decision last year to limit exports of
certain critical minerals, we made the strategic decision to
transition away from a germanium-dependent business. Despite this
headwind, I am proud to say we were able to hold revenue near level
for the year compared to the prior year. Moving away from Germanium
has allowed us to more fully turn toward our own proprietary Black
Diamond glass materials and, in some instances, further induce
customers to partner with us on their designs to incorporate our
materials. In July, we announced that a major defense customer did
exactly this, qualifying a new optics design incorporating our
BlackDiamond glass. An order is expected once the customer
completes current demand using its inventory of Germanium."
2024 Fiscal Fourth Quarter Financial Results
Revenue for the fourth quarter of fiscal 2024 was approximately
$8.6 million, a decrease of
approximately $1.1 million, or 11%,
as compared to approximately $9.7
million in the same quarter of the prior fiscal year.
Revenue among our product groups for the fourth quarter of fiscal
2024 was as follows:
Product Group
Revenue
($ in millions)**
|
Fourth Quarter
of Fiscal 2024
|
Fourth Quarter
of Fiscal 2023
|
%
Change
|
Infrared ("IR")
components
|
$3.0
|
$4.8
|
-36 %
|
Visible
components
|
$3.2
|
$3.2
|
0 %
|
Assemblies &
modules
|
$1.4
|
$1.6
|
-14 %
|
Engineering
services
|
$1.0
|
$0.1
|
698 %
|
** Numbers may not foot
due to rounding
|
- Revenue generated by IR components was approximately
$3.0 million in the fourth quarter of
fiscal 2024, a decrease of approximately $1.7 million, or 36%, as compared to the same
quarter of the prior fiscal year. The decrease in revenue is
primarily due to a decrease in sales against a large annual
contract for Germanium-based products, which was not renewed in the
second quarter of fiscal year 2024, as we decided to reduce the
amount of optics we produce from Germanium, both to reduce our risk
of supply chain disruption, and more importantly, to work with
customers to convert their systems to use optics made of our own
BlackDiamond materials.
- Revenue generated by visible components was approximately
$3.2 million, which was about the
same in comparison to the same quarter of the prior fiscal year,
with a decrease in sales to defense customers due to timing of
orders offset by an increase in sales through U.S. catalog and
distribution channels.
- Revenue from assemblies and modules decreased by $0.2 million for the fourth quarter of fiscal
2024, as compared to the same quarter of the prior fiscal year,
primarily due to lower sales of a custom visible lens assembly to a
medical customer for which we have an end-of-life order in backlog
going into fiscal 2025. In the fourth quarter of fiscal year 2023,
this customer requested a greater number of units shipped, whereas
in fiscal year 2024 we have shipped a lower but more consistent
amount each quarter. This decrease was partially offset by the
addition of Visimid revenue.
- Revenue from engineering services was $1.0 million for the fourth quarter of fiscal
2024, an increase of $0.9 million as
compared to the same quarter of the prior fiscal year. This
increase was primarily driven by Visimid's contract with Lockheed
Martin, where revenue is generally recognized based on the
achievement of milestones.
Gross margin in the fourth quarter of fiscal 2024 was
approximately $2.5 million, a
decrease of $0.6 million, or 18%, as
compared to the same quarter of the prior fiscal year. Total cost
of sales was approximately $6.1
million for the fourth quarter of fiscal 2024, compared to
approximately $6.6 million for the
same quarter of the prior fiscal year. Gross margin as a percentage
of revenue was 29% for the fourth quarter of fiscal 2024, compared
to 32% for the same quarter of the prior fiscal year. The decrease
in gross margin as a percentage of revenue is primarily due to the
overall decrease in revenue, resulting in a lower contribution to
our fixed manufacturing costs. Sequentially, gross margin improved
from 21% in the third quarter of fiscal 2024 as we moved past the
inventory revaluation which negatively impacted that quarter.
Selling, general and administrative ("SG&A") costs were
approximately $3.6 million for the
fourth quarter of fiscal 2024, an increase of approximately
$0.6 million, or 20%, as compared to
the same quarter of the prior fiscal year. The increase in SG&A
for the fourth quarter of fiscal 2024 is primarily due to an
increase in wages, including non-recurring executive severance
costs of $0.1 million, and an
increase in legal and consulting fees related to business
development initiatives. We also incurred additional legal
and professional fees associated with the previously disclosed
Delaware chancery court
proceedings related to various corporate matters.
Net loss for the fourth quarter of fiscal 2024 was approximately
$2.4 million, or $0.06 basic and diluted loss per share, compared
to $0.8 million, or $0.02 basic and diluted loss per share, for the
same quarter of the prior fiscal year. The increase in net loss of
approximately $1.5 million for the
fourth quarter of fiscal 2024, as compared to the same quarter of
the prior fiscal year, was primarily attributable to the decrease
in gross margin, coupled with increased operating expenses,
including amortization of intangibles.
EBITDA* for the quarter ended June 30,
2024 was a loss of approximately $1.3
million, compared to income of $0.1
million for the same period of the prior fiscal year.
The decrease in EBITDA in the fourth quarter of fiscal year 2024
was primarily attributable to the decrease in revenue and gross
margin, coupled with increases in SG&A and Other expenses, net,
which expense increases primarily related to non-recurring
items.
2024 Fiscal Year Financial Results
Revenue for fiscal 2024 was approximately $31.7 million, a decrease of approximately
$1.2 million, or 4%, as compared to
approximately $32.9 million in the
same period of the prior fiscal year. The decrease was
primarily driven by a decrease in sales of visible components,
partially offset by increases in sales of IR components and
engineering services. Revenue among our product groups for fiscal
2024 was as follows:
Product Group
Revenue ($ in
millions)**
|
Fiscal
2024
|
Fiscal
2023
|
%
Change
|
Infrared ("IR")
components
|
$14.1
|
$14.4
|
-2 %
|
Visible
components
|
$11.2
|
$13.4
|
-16 %
|
Assemblies &
modules
|
$4.5
|
$4.7
|
-5 %
|
Engineering
services
|
$2.0
|
$0.4
|
363 %
|
** Numbers may not foot
due to rounding
|
- Revenue generated by IR components was approximately
$14.1 million in fiscal 2024, a
decrease of approximately $0.3
million, or 2%, as compared to the prior fiscal year. The
decrease in revenue related to the Germanium-based annual contract
that was not renewed was mostly offset by an increase in shipments
against an annual contract for an international military program.
This contract was renewed during the first quarter of fiscal 2024
for a higher dollar value than the previous contract.
- Revenue generated by visible components was approximately
$11.2 million in fiscal 2024, a
decrease of approximately $2.2
million, or 16%, as compared to the prior fiscal year. The
decrease in revenue is primarily due to a decrease in sales to
customers in the defense industry, as well as a decrease in sales
through catalog and distribution channels in the U.S. and in
Europe. Sales to customers in the
telecommunications industry in China also decreased.
- Revenue from assemblies and modules was approximately
$4.5 million in fiscal 2024, a
decrease of approximately $0.2
million, or 5%, as compared to the prior fiscal year,
primarily due to a decrease in shipments against a multi-year
contract with a defense customer due to timing, as well as
decreases in sales of infrared assemblies to industrial customers
in China and the U.S.. Customers
in both regions have been steadily decreasing orders since the peak
of COVID-19. These decreases were partially offset by the addition
of revenue from sales of infrared camera cores.
- Revenue from engineering services was approximately
$2.0 million for fiscal 2024, an
increase of $1.5 million as compared
to the prior fiscal year. This increase was primarily driven by our
contract with Lockheed Martin, where revenue is generally
recognized based on the achievement of milestones. The remaining
increase is driven by revenue from one of our space-related funded
research contracts.
Gross margin for fiscal 2024 was approximately $8.6 million, a decrease of 22%, as compared to
approximately $11.1 million in fiscal
year 2023. Gross margin as a percentage of revenue was 27%
for fiscal year 2024 as compared to 34% for fiscal year 2023. The
decrease in gross margin as a percentage of revenue is primarily
due to the decrease in visible components sales, which typically
have higher margins than our infrared components product group. Our
infrared components product group comprised a greater portion of
our sales for fiscal year 2024. In addition, gross margin as a
percentage of revenue for fiscal year 2024 was unfavorably impacted
by the revaluation of inventory during the third quarter of fiscal
2024. The revaluation resulted in a net write-down of
inventory.
SG&A costs were approximately $12.3
million for fiscal 2024, an increase of approximately
$0.9 million, or 8%, as compared to
the prior fiscal year. The increase in SG&A for fiscal 2024 is
primarily due to an increase in wages, including non-recurring
executive severance costs of $0.1
million, and an increase in legal and consulting fees
related to business development initiatives. These increases
are partially offset by a decrease in stock-based compensation,
whereas fiscal 2023 included increased stock compensation costs
associated with two director retirements. We also incurred
additional legal and professional fees in fiscal 2024 associated
with our rescheduled annual stockholder meeting and previously
disclosed Delaware chancery court
proceedings. We expect SG&A costs to remain elevated for the
next few quarters as we continue with certain business development
initiatives.
Net loss for fiscal 2024 was approximately $8.0 million, or $0.21 basic and diluted loss per share, compared
to approximately $4.0 million, or
$0.13 basic and diluted loss per
share, for fiscal 2023. The increase in net loss for fiscal
2024, as compared to fiscal 2023, is attributable to the
approximately $4.3 million increase
in operating loss resulting from lower revenue and gross margin and
increased operating expenses. This decrease was partially offset by
a decrease in other expense, net, of approximately $0.1 million, primarily due to the decrease in
interest expense. In addition, there was a favorable difference of
approximately $0.2 million in the
provision for income taxes for fiscal 2024 as compared to fiscal
2023.
EBITDA* for fiscal 2024 was a loss of approximately $3.7 million, compared to $0.4 million for fiscal 2023. The decrease
in EBITDA for fiscal 2024 is primarily attributable to lower
revenue and gross margin, coupled with increased operating
expenses, including SG&A and new product development. SG&A
for fiscal 2024 includes a number of non-recurring cost items,
particularly as related to the recently announced acquisition.
Liquidity and Capital Resources
Cash provided by operations was approximately $0.5 million for fiscal 2024, compared to cash
used in operations of approximately $2.8
million for the prior fiscal year. The increase in cash
flows from operations during fiscal year 2024 is primarily due
decreases in accounts receivable and inventory, due to lower sales
in fiscal year 2024, as compared to fiscal year 2023. Cash used in
operations for fiscal year 2023 was primarily due to an increase in
accounts receivable, due to higher sales in the fourth quarter of
fiscal year 2023, and an increase in inventory during the second
half of fiscal year 2023. The cash outflow for accounts payable and
accrued liabilities for fiscal year 2023 was largely due to the
previously described events that occurred at our Chinese
subsidiaries, for which certain expenses were accrued as of
June 30, 2021 and paid during fiscal
years 2022 and 2023.
Capital expenditures were approximately $2.2 million for fiscal 2024, compared to
approximately $3.1 million in the
prior fiscal year. The Company also expended
approximately $0.8 million, net of
cash acquired, to acquire Visimid during fiscal 2024. Fiscal year
2024 also reflects proceeds of approximately $0.4 million from sale-leasebacks of equipment.
During fiscal years 2024 and 2023, our capital expenditures were
primarily related to the expansion of our Orlando facility. In August 2023, we completed the construction of
certain tenant improvements subject to our continuing lease for our
Orlando facility, of which the
landlord provided $2.4 million in
tenant improvement allowances. We funded the balance of the tenant
improvement costs of approximately $3.7
million in fiscal years 2023 and 2024.
Sales Backlog
Our total backlog as of June 30,
2024, was approximately $19.3
million, a decrease of 11%, as compared to $21.7 million as of June
30, 2023. The decrease in backlog during fiscal 2024 as
compared fiscal 2023 is primarily due to fiscal 2024 shipments
against the prior period backlog under several annual and
multi-year contract renewals. The timing of multi-year contract
renewals are not always consistent and, thus, backlog levels may
increase substantially when annual and multi-year orders are
received and decrease as shipments are made against these orders.
We anticipate that our existing annual and multi-year contracts
will be renewed in foreseeable future quarters. The reduction in
backlog as a result of these shipments during fiscal 2024 were
partially offset by the following: (i) a significant contract
renewal (represented a 40% increase in dollar value as compared to
the previous order) for advanced infrared optics for a
critical international military program; and (ii) a significant
contract awarded to Visimid by Lockheed Martin in December 2023. In previous years we have
typically received a significant contract renewal during our second
fiscal quarter from our largest customer for infrared products made
of Germanium. However, as previously disclosed we have decided to
reduce the amount of optics we produce from Germanium, both to
reduce our risk of supply chain disruption and, more importantly,
to work with customers to convert their systems to use optics made
of our own BlackDiamond materials. As such, in the second quarter
of fiscal 2024 we did not book our typical annual renewal order for
Germanium optics with this customer. Instead, we continue to work
with this customer, as well as other customers, to convert their
systems to use BlackDiamond optics, which we believe will result in
future orders to replace the orders for Germanium-based optics.
Investor Conference Call and Webcast Details
LightPath will host an audio conference call and webcast on
Thursday, September 19, 2024, at
5:00 p.m. ET to discuss its financial
and operational performance for its fiscal 2024 fourth quarter and
full year.
Date: Thursday, September 19,
2024
Time: 5:00 p.m. (ET)
Dial-in Number: 1-877-317-2514
International Dial-in Number: 1-412-317-2514
Webcast: 4Q24 Webcast Link
Participants are recommended to dial-in or log-on approximately
10 minutes prior to the start of the event. A replay of the call
will be available approximately one hour after completion through
October 3, 2024. To listen to the
replay, dial 1-877-344-7529 (domestic) or 1-412-317-0088
(international), and enter conference ID #7324919.
*Use of Non-GAAP Financial Measures
To provide investors with additional information regarding
financial results, this press release includes references to
EBITDA, which is a non-GAAP financial measure. For a reconciliation
of this non-GAAP financial measure to the most directly comparable
financial measure calculated in accordance with GAAP, see the table
provided in this press release.
A "non-GAAP financial measure" is generally defined as a
numerical measure of a company's historical or future performance
that excludes or includes amounts, or is subject to adjustments, so
as to be different from the most directly comparable measure
calculated and presented in accordance with GAAP. The Company's
management believes that this non-GAAP financial measure, when
considered together with the GAAP financial measure, provide
information that is useful to investors in understanding
period-over-period operating results separate and apart from items
that may, or could, have a disproportionately positive or negative
impact on results in any particular period. Management also
believes that this non-GAAP financial measure enhances the ability
of investors to analyze underlying business operations and
understand performance. In addition, management may utilize these
non-GAAP financial measures as guides in forecasting, budgeting,
and planning. Non-GAAP financial measures should be considered in
addition to, and not as a substitute for, or superior to, financial
measures presented in accordance with GAAP.
The Company calculates EBITDA by adjusting net income to exclude
net interest expense, income tax expense or benefit, depreciation,
and amortization.
About LightPath Technologies
LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading global,
vertically integrated provider of optics, photonics and infrared
solutions for the industrial, commercial, defense,
telecommunications, and medical industries. LightPath designs and
manufactures proprietary optical and infrared components including
molded glass aspheric lenses and assemblies, custom molded glass
freeform lenses, infrared lenses and thermal imaging assemblies,
fused fiber collimators, and proprietary BlackDiamond™ ("BD6")
chalcogenide-based glass lenses. LightPath also offers custom
optical assemblies, including full engineering design support. The
Company is headquartered in Orlando,
Florida, with manufacturing and sales offices in
Dallas, Texas, Latvia and China.
LightPath's wholly-owned subsidiary, Visimid Technologies, was
acquired in July 2023, and
specializes in the design and development of customized infrared
cameras, for the industrial and defense industries. Such customized
cameras are often sold together with customized optical assemblies
from LightPath.
LightPath's wholly-owned subsidiary, ISP Optics Corporation,
manufactures a full range of infrared products from high
performance MWIR and LWIR lenses and lens assemblies. ISP's
infrared lens assembly product line includes athermal lens systems
used in cooled and un-cooled thermal imaging cameras. Manufacturing
is performed in-house to provide precision optical components
including spherical, aspherical and diffractive coated infrared
lenses.
For more information on LightPath and its businesses, please
visit www.lightpath.com.
Forward-Looking Statements
This press release includes statements that constitute
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by the use of words
such as "forecast," "guidance," "plan," "estimate," "will,"
"would," "project," "maintain," "intend," "expect," "anticipate,"
"prospect," "strategy," "future," "likely," "may," "should,"
"believe," "continue," "opportunity," "potential," and other
similar expressions that predict or indicate future events or
trends or that are not statements of historical matters. These
forward-looking statements are based on information available at
the time the statements are made and/or management's good faith
belief as of that time with respect to future events and are
subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in or suggested by the
forward-looking statements. Factors that could cause or contribute
to such differences include, but are not limited to, the impact of
varying demand for the Company products; the ability of the Company
to obtain needed raw materials and components from its suppliers;
general economic uncertainty in key global markets and a worsening
of global economic conditions or low levels of economic
growth; geopolitical tensions, the Russian-Ukraine
conflict, and the Hamas/Israel
war; the effects of steps that the Company could take
to reduce operating costs; rising inflation and increased interest
rates, which diminish capital market cash flow and borrowing power;
the inability of the Company to sustain profitable sales growth,
convert inventory to cash, or reduce its costs to maintain
competitive prices for its products; circumstances or developments
that may make the Company unable to implement or realize the
anticipated benefits, or that may increase the costs, of its
current and planned business initiatives; and those factors
detailed by LightPath Technologies, Inc. in its public filings with
the Securities and Exchange Commission, including its Annual Report
on Form 10-K and Quarterly Reports on 10-Q. Should one or more of
these risks, uncertainties, or facts materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those indicated or anticipated by the
forward-looking statements contained herein. Accordingly, you are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made.
Forward-looking statements should not be read as a guarantee of
future performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. Except as required under the federal
securities laws and the rules and regulations of the Securities and
Exchange Commission, we do not have any intention or obligation to
update publicly any forward-looking statements, whether as a result
of new information, future events, or otherwise.
(tables follow)
LIGHTPATH TECHNOLOGIES, INC.
|
Condensed Consolidated Balance
Sheets
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
June 30,
|
Assets
|
2024
|
|
2023
|
Current
assets:
|
|
|
|
|
|
Cash and cash
equivalents
|
$
3,480,268
|
|
$
4,687,004
|
|
Restricted
cash
|
—
|
|
2,457,486
|
|
Trade accounts
receivable, net of allowance of $25,676 and $18,502
|
4,928,931
|
|
6,634,574
|
|
Inventories,
net
|
6,551,059
|
|
7,410,734
|
|
Prepaid expenses and
deposits
|
445,900
|
|
570,293
|
|
Other current
assets
|
131,177
|
|
—
|
|
|
|
|
Total current
assets
|
15,537,335
|
|
21,760,091
|
|
|
|
|
|
|
|
|
Property and equipment,
net
|
15,210,612
|
|
12,810,930
|
Operating lease
right-of-use assets
|
6,741,549
|
|
9,571,604
|
Intangible assets,
net
|
3,650,739
|
|
3,332,715
|
Goodwill
|
|
|
6,764,127
|
|
5,854,905
|
Deferred tax assets,
net
|
123,000
|
|
140,000
|
Other assets
|
|
59,602
|
|
65,939
|
|
|
|
|
Total assets
|
$ 48,086,964
|
|
$ 53,536,184
|
Liabilities and Stockholders'
Equity
|
|
|
|
Current
liabilities:
|
|
|
|
|
Accounts
payable
|
$
3,231,713
|
|
$
2,574,135
|
|
Accrued
liabilities
|
1,911,867
|
|
662,242
|
|
Accrued payroll and
benefits
|
1,446,452
|
|
1,499,896
|
|
Operating lease
liabilities, current
|
1,059,998
|
|
969,890
|
|
Loans payable, current
portion
|
209,170
|
|
1,023,814
|
|
Finance lease
obligation, current portion
|
177,148
|
|
103,646
|
|
|
|
|
Total current
liabilities
|
8,036,348
|
|
6,833,623
|
|
|
|
|
|
|
|
|
Deferred tax
liabilities, net
|
326,197
|
|
465,000
|
Accrued liabilities,
noncurrent
|
611,619
|
|
—
|
Finance lease
obligation, less current portion
|
528,753
|
|
341,201
|
Operating lease
liabilities, noncurrent
|
8,058,502
|
|
8,393,248
|
Loans payable, less
current portion
|
325,880
|
|
1,550,587
|
|
|
|
Total
liabilities
|
17,887,299
|
|
17,583,659
|
|
|
|
|
|
|
|
|
Commitments and
Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
Preferred stock: Series
D, $.01 par value, voting;
|
|
|
|
|
|
500,000 shares
authorized; none issued and outstanding
|
—
|
|
—
|
|
Common stock:
Class A, $.01 par value, voting;
|
|
|
|
|
|
94,500,000 and
44,500,000 shares authorized;
|
|
|
|
|
|
39,254,643 and
34,344,739 shares issued and outstanding
|
392,546
|
|
373,447
|
|
Additional paid-in
capital
|
245,140,758
|
|
242,808,771
|
|
Accumulated other
comprehensive income
|
509,936
|
|
606,536
|
|
Accumulated
deficit
|
(215,843,575)
|
|
(207,836,229)
|
|
|
|
|
Total stockholders'
equity
|
30,199,665
|
|
35,952,525
|
|
|
|
|
Total liabilities and
stockholders' equity
|
$ 48,086,964
|
|
$ 53,536,184
|
|
|
|
|
|
|
|
|
LIGHTPATH TECHNOLOGIES, INC.
|
Condensed Consolidated Statements of Comprehensive
Income (Loss)
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
|
|
June 30,
|
|
June 30,
|
|
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue, net
|
$
8,634,132
|
|
$
9,684,721
|
|
$ 31,726,192
|
|
$32,933,949
|
Cost of
sales
|
6,109,100
|
|
6,603,559
|
|
23,094,946
|
|
21,859,126
|
|
|
|
Gross margin
|
2,525,032
|
|
3,081,162
|
|
8,631,246
|
|
11,074,823
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Selling, general and
administrative
|
3,605,988
|
|
3,009,109
|
|
12,297,383
|
|
11,437,241
|
|
New product
development
|
582,822
|
|
615,675
|
|
2,400,420
|
|
2,145,413
|
|
Amortization of
intangible assets
|
434,403
|
|
281,271
|
|
1,635,523
|
|
1,125,083
|
|
Loss (gain) on disposal
of property and equipment
|
111,336
|
|
(22,463)
|
|
124,584
|
|
(78,373)
|
|
|
|
Total operating
expenses
|
4,734,549
|
|
3,883,592
|
|
16,457,910
|
|
14,629,364
|
|
|
|
Operating
loss
|
(2,209,517)
|
|
(802,430)
|
|
(7,826,664)
|
|
(3,554,541)
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
Interest expense,
net
|
(42,814)
|
|
(54,561)
|
|
(191,862)
|
|
(283,266)
|
|
Other income (expense),
net
|
(155,354)
|
|
59,769
|
|
78,670
|
|
24,970
|
|
Total other income
(expense), net
|
(198,168)
|
|
5,208
|
|
(113,192)
|
|
(258,296)
|
|
|
|
Loss before income
taxes
|
(2,407,685)
|
|
(797,222)
|
|
(7,939,856)
|
|
(3,812,837)
|
Income tax
provision
|
(53,912)
|
|
11,618
|
|
67,490
|
|
234,034
|
|
|
|
Net loss
|
$
(2,353,773)
|
|
$
(808,840)
|
|
$
(8,007,346)
|
|
$
(4,046,871)
|
Foreign currency
translation adjustment
|
(119,009)
|
|
(370,492)
|
|
(96,600)
|
|
(328,589)
|
|
|
|
Comprehensive
loss
|
$
(2,472,782)
|
|
$
(1,179,332)
|
|
$
(8,103,946)
|
|
$
(4,375,460)
|
Loss per common share
(basic)
|
$
(0.06)
|
|
$
(0.02)
|
|
$
(0.21)
|
|
$
(0.13)
|
Number of shares used
in per share calculation (basic)
|
38,850,526
|
|
37,320,084
|
|
37,944,935
|
|
31,637,445
|
Loss per common share
(diluted)
|
$
(0.06)
|
|
$
(0.02)
|
|
$
(0.21)
|
|
$
(0.13)
|
Number of shares used
in per share calculation (diluted)
|
38,850,526
|
|
37,320,084
|
|
37,944,935
|
|
31,637,445
|
|
|
|
|
|
|
|
|
|
|
|
|
LIGHTPATH
TECHNOLOGIES, INC.
|
Condensed
Consolidated Statements of Changes in Stockholders'
Equity
|
(unaudited)
|
|
|
|
|
|
Accumulated
|
|
|
|
|
Class
A
|
Additional
|
Other
|
|
Total
|
|
|
Common
Stock
|
Paid-in
|
Comphrehensive
|
Accumulated
|
Stockholders'
|
|
|
Shares
|
Amount
|
Capital
|
Income
|
Deficit
|
Equity
|
Balances at June 30,
2022
|
|
27,046,790
|
$
270,468
|
$
232,315,003
|
$
935,125
|
$
(203,789,358)
|
$
29,731,238
|
Issuance of common
stock for:
|
|
|
|
|
|
|
|
|
Employee
Stock Purchase Plan
|
|
33,523
|
335
|
40,045
|
—
|
—
|
40,380
|
|
Exercise
of Stock Options, RSUs & RSAs, net
|
|
1,173,516
|
11,735
|
34,165
|
—
|
—
|
45,900
|
|
Issuance
of common stock under public equity placement
|
|
9,090,910
|
90,909
|
9,108,601
|
—
|
—
|
9,199,510
|
Stock-based
compensation on stock options, RSAs & RSUs
|
|
—
|
—
|
1,310,957
|
—
|
—
|
1,310,957
|
Foreign currency
translation adjustment
|
|
—
|
—
|
—
|
(328,589)
|
—
|
(328,589)
|
Net loss
|
|
—
|
—
|
—
|
—
|
(4,046,871)
|
(4,046,871)
|
Balances at June 30,
2023
|
|
37,344,739
|
373,447
|
242,808,771
|
606,536
|
(207,836,229)
|
35,952,525
|
Issuance of common
stock for:
|
|
|
|
|
|
|
|
|
Employee
Stock Purchase Plan
|
|
30,447
|
304
|
39,373
|
—
|
—
|
39,677
|
|
Exercise
of Stock Options, RSUs & RSAs, net
|
|
945,188
|
9,452
|
(9,452)
|
—
|
—
|
—
|
|
Issuance
of common stock under public equity placement
|
|
585,483
|
5,855
|
800,477
|
—
|
—
|
806,332
|
|
Issuance
of common stock for acquisition of Visimid
|
|
348,786
|
3,488
|
482,566
|
—
|
—
|
486,054
|
Stock-based
compensation on stock options, RSUs & RSAs
|
|
—
|
—
|
1,019,023
|
—
|
—
|
1,019,023
|
Foreign currency
translation adjustment
|
|
—
|
—
|
—
|
(96,600)
|
—
|
(96,600)
|
Net loss
|
|
—
|
—
|
—
|
—
|
(8,007,346)
|
(8,007,346)
|
Balances at June 30,
2024
|
|
39,254,643
|
$
392,546
|
$
245,140,758
|
$
509,936
|
$
(215,843,575)
|
$
30,199,665
|
|
|
|
|
|
|
|
|
LIGHTPATH TECHNOLOGIES, INC.
|
Condensed Consolidated Statements of Cash
Flows
|
(unaudited)
|
|
|
|
|
|
Year Ended June 30,
|
|
2024
|
|
2023
|
Cash flows from
operating activities:
|
|
|
|
Net loss
|
$
(8,007,346)
|
|
$
(4,046,871)
|
Adjustments to
reconcile net loss to net cash provided by (used in) operating
activities:
|
|
|
|
Depreciation and
amortization
|
4,048,409
|
|
3,174,569
|
Interest from
amortization of debt costs
|
—
|
|
58,774
|
Loss (gain) on
disposal of property and equipment
|
124,584
|
|
(78,373)
|
Stock-based
compensation on stock options, RSUs & RSAs, net
|
1,019,023
|
|
1,310,957
|
Provision for credit
losses
|
(4,426)
|
|
8,158
|
Change in operating
lease assets and liabilities
|
183,393
|
|
(231,561)
|
Inventory write-offs
to allowance
|
136,676
|
|
316,297
|
Deferred
taxes
|
(121,803)
|
|
(73,015)
|
Changes in operating
assets and liabilities:
|
|
|
|
Trade accounts
receivable
|
1,498,698
|
|
(1,431,440)
|
Other current
assets
|
(131,177)
|
|
-
|
Inventories
|
960,739
|
|
(741,604)
|
Prepaid expenses and
deposits
|
133,810
|
|
(97,792)
|
Accounts payable and
accrued liabilities
|
680,457
|
|
(977,622)
|
Net cash provided by
(used in) operating activities
|
521,037
|
|
(2,809,523)
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
Purchase of property
and equipment
|
(2,182,805)
|
|
(3,077,154)
|
Proceeds from sales of
equipment
|
—
|
|
209,169
|
Proceeds from
sale-leaseback of equipment
|
364,710
|
|
—
|
Acquisition of Visimid
Technologies, net of cash acquired
|
(847,141)
|
|
—
|
Net cash used in
investing activities
|
(2,665,236)
|
|
(2,867,985)
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
Proceeds from sale of
common stock from Employee Stock Purchase Plan
|
39,677
|
|
40,380
|
Proceeds from issuance
of common stock under public equity placement
|
806,332
|
|
9,199,510
|
Borrowings on loans
payable
|
278,926
|
|
141,245
|
Payments on loans
payable
|
(2,459,474)
|
|
(1,852,256)
|
Repayment of finance
lease obligations
|
(131,901)
|
|
(73,003)
|
Net cash (used in)
provided by financing activities
|
(1,466,440)
|
|
7,455,876
|
Effect of exchange rate
on cash and cash equivalents
|
(53,583)
|
|
(141,769)
|
Change in cash, cash
equivalents and restricted cash
|
(3,664,222)
|
|
1,636,599
|
Cash, cash equivalents
and restricted cash, beginning of period
|
7,144,490
|
|
5,507,891
|
Cash, cash equivalents
and restricted cash, end of period
|
$
3,480,268
|
|
$
7,144,490
|
|
|
|
|
Supplemental disclosure
of cash flow information:
|
|
|
|
Interest paid in
cash
|
$
196,541
|
|
$
221,773
|
Income taxes
paid
|
$
166,858
|
|
$
428,914
|
Supplemental
disclosure of non-cash investing & financing
activities:
|
|
|
|
Purchase of
equipment through finance lease arrangements
|
$
396,058
|
|
$
451,058
|
Equipment
deposit paid in restricted stock
|
—
|
|
$
45,900
|
Operating
right-of-use assets acquired in exchange for operating lease
liabilities
|
$
92,136
|
|
—
|
|
|
|
|
To supplement our consolidated financial statements presented in
accordance with U.S. GAAP, we provide additional non-GAAP financial
measures. Our management believes these non-GAAP financial
measures, when considered together with the GAAP financial
measures, provide information that is useful to investors in
understanding period-over-period operating results separate and
apart from items that may or could, have a disproportionally
positive or negative impact on results in any particular period.
Our management also believes that these non-GAAP financial measures
enhance the ability of investors to analyze our underlying business
operations and understand our performance. In addition, our
management may utilize these non-GAAP financial measures as guides
in forecasting, budgeting, and planning. Any analysis on non-GAAP
financial measures should be used in conjunction with results
presented in accordance with GAAP. A reconciliation of these
non-GAAP financial measures with the most directly comparable
financial measures calculated in accordance with GAAP is presented
in the tables below.
LIGHTPATH TECHNOLOGIES, INC.
|
Reconciliation of Non-GAAP Financial Measures and
Regulation G Disclosure
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
Three Months Ended June 30,
|
|
Year Ended June 30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net loss
|
$
(2,353,773)
|
|
$
(808,840)
|
|
$
(8,007,346)
|
|
$
(4,046,871)
|
Depreciation and
amortization
|
1,062,559
|
|
815,019
|
|
4,048,409
|
|
3,174,569
|
Income tax
provision
|
(53,912)
|
|
11,618
|
|
67,490
|
|
234,034
|
Interest
expense
|
42,814
|
|
54,561
|
|
191,862
|
|
283,266
|
|
EBITDA
|
$
(1,302,312)
|
|
$
72,358
|
|
$
(3,699,585)
|
|
$
(355,002)
|
|
% of revenue
|
-15 %
|
|
1 %
|
|
-12 %
|
|
-1 %
|
|
|
|
|
|
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-fiscal-2024-fourth-quarter-and-full-year-financial-results-302253524.html
SOURCE LightPath Technologies